Covalon Technologies Ltd. has achieved Depository Trust Company (DTC) eligibility, allowing its shares to be traded electronically in the US and enhancing its market access and liquidity.

Covalon Technologies Ltd. has reported its fifth consecutive quarter of positive earnings, driven by 21% year-over-year revenue growth and a strong focus on key priorities in the biotechnology sector.